Skip to content

Cannabis: all studies

Page 172 of 287: studies 1,711 to 1,720 of 2,864, newest first. Back to the cannabis overview

Research

Delta 9-tetrahydrocannabinol-induced alterations in limbic system glucose use in the rat.

Neuroreport November 16, 2001 Ros R Brett, F MacKenzie, Judith A Pratt

The effects of Delta9-tetrahydrocannabinol (THC) on neural activity in the rat were investigated using [14C]2-deoxyglucose autoradiography to measure local cerebral glucose use. Overall, THC reduced glucose use at 5 mg/kg and slightly increased it at 1 mg/kg. Significant reductions were seen at the higher dose in regions of the hippocampus and limbic system, and in structures associated with...

Effects of acute smoked marijuana on complex cognitive performance.

Neuropsychopharmacology November 2001 Carl L. Hart, W Van Gorp, Margaret Haney et al.

Although the ability to perform complex cognitive operations is assumed to be impaired following acute marijuana smoking, complex cognitive performance after acute marijuana use has not been adequately assessed under experimental conditions. In the present study, we used a within-participant double-blind design to evaluate the effects acute marijuana smoking on complex cognitive performance in...

Cannabis‐induced Koro in Americans

Addiction November 1, 2001 Mitch Earleywine 57 citations

AIMS: Koro, an acute panic reaction related to the perception of penile retraction, was once considered limited to specific cultures. The disorder has appeared as part of a panic response to cannabis, but only in citizens of India. This study looked for cannabis-induced Koro in Americans. DESIGN: Given the relative rarity of cannabis-induced Koro, this work focused on individual case studies....

Marijuana abstinence effects in marijuana smokers maintained in their home environment.

Archives of General Psychiatry October 2001 A J Budney, J R Hughes, B A Moore et al.

Although withdrawal symptoms are commonly reported by persons seeking treatment for marijuana dependence, the validity and clinical significance of a marijuana withdrawal syndrome has not been established. This controlled outpatient study examined the reliability and specificity of the abstinence effects that occur when daily marijuana users abruptly stop smoking marijuana. Twelve daily...

(R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide.

Psychopharmacology August 2001 Torbjörn U C Järbe, R J Lamb, S Lin et al.

(R)-methanandamide (AM-356), a metabolically more stable chiral analog of the endocannabinoid ligand anandamide, was used as a representative of fatty acid ethanolamide CB1 receptor ligands to characterize the discriminative stimulus functions of anandamides. Rats discriminated between 10 mg/kg (R)-methanandamide and vehicle administered IP 15 min prior to session onset. Another group of rats...

[Cannabis consumption and its psychosocial effects in a comparison of different cultures].

Fortschritte der Neurologie · Psychiatrie August 1, 2001 J Schlimme, D Rada, Udo Schneider

Cannabis consumption is a social and cultural phenomenon. It has a specific place in each society, therefore psychotropic effects are judged differently. In medieval Islam cannabis consumption showed connections with religious and mystic events and was basically formed through consuming sufis. The main risk of cannabis use was especially the induction of "madness" or psychotic states in case of...

The pharmacological activity of inhalation exposure to marijuana smoke in mice.

Drug and Alcohol Dependence July 1, 2001 Aron H Lichtman, Justin L. Poklis, Alphonse Poklis et al.

Although the majority of cannabinoid users smoke marijuana, the preponderance of laboratory animal research is based on administration of Delta9-tetrahydrocannabinol (Delta9-THC) or other cannabinoid agents via injection. The aim of the present study was to evaluate the impact of inhaling marijuana, or ethanol-extracted placebo smoke in the mouse model of cannabinoid activity by assessing...

Chronic treatment with Delta(9)-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction.

Neuropharmacology July 1, 2001 S Lamarque, K Taghzouti, H Simon

Cannabis sativa preparations are some of the most widely used illicit recreational drugs. In addition to their direct addictive potential, cannabinoids may influence the sensitivity to other drugs. The aim of the present study was to determine if a cross-sensitization between Delta(9)-tetrahydrocannabinol (Delta(9)-THC) and other drugs (amphetamine and heroin) could be demonstrated. We examined...

Differential role of the nitric oxide pathway on delta(9)-THC-induced central nervous system effects in the mouse.

European Journal of Neuroscience February 2001 S C Azad, Giovanni Marsicano, I Eberlein et al.

This study investigated whether the nitric oxide pathway was involved in the central effects of Delta(9)-tetrahydrocannabinol (Delta(9)-THC), the major psychoactive constituent of cannabis sativa. Body temperature, nociception and locomotion were measured in neuronal nitric oxide synthase (nNOS) knock-out (KO) mice and wild-type (WT) controls after intraperitoneal application of Delta(9)-THC....

Psychiatric effects of cannabis

The British Journal of Psychiatry February 1, 2001 Andrew Johns 474 citations

BACKGROUND: Cannabis is commonly regarded as an innocuous drug and the prevalence of lifetime and regular use has increased in most developed countries. However, accumulative evidence highlights the risks of dependence and other adverse effects, particularly among people with pre-existing psychiatric disorders. AIMS: To re-evaluate the adverse effects of cannabis in the general population and...